EUVIMEDPoznaj EUVIMED
Crossref

Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis

Xing Liu iD, Xiuwen Zhai, Xiaoyu Wang, Xiaodong Zhu, Ziyue Wang, Zhengyu Jiang, Hao Bao, ZhaoHong Chen

Antioxidants & Redox Signaling · 2025-05-01 · 42 (13-15) · 787-806

DOI: 10.1089/ars.2024.0653 ↗

At a glance

Journal article in Antioxidants & Redox Signaling, published on 2025-05-01. Written by Xing Liu and 7 co-authors. Institution: National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China. Major MEDLINE topics: Podocytes, Diabetic Nephropathies, Oxidative Stress, NF-E2-Related Factor 2. Cited 11 times so far (Crossref); 79 references.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Aims

Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease, and podocyte injury is one of the major contributors to DKD. As a crucial transcriptional factor that regulates cellular response to oxidative stress, nuclear factor erythroid 2-related factor 2 (Nrf2) is an attractive therapeutic target for DKD. In this study, we evaluated the therapeutic potential of DDO-1039, a novel small-molecule Nrf2 activator developed with protein-protein interaction strategy, on podocyte injury in DKD.

Results

DDO-1039 treatment significantly increased Nrf2 protein level and Nrf2 nuclear translocation, thereby upregulating Nrf2 target genes [heme oxygenase 1, NAD(P)H quinone dehydrogenase 1, glutamate-cysteine ligase modifier, and tyrosine-protein kinase receptor] both in vitro and in vivo. DDO-1039 attenuated glomerular sclerosis and podocyte injury in the high-fat diet/streptozotocin-induced (HFD/STZ) diabetic mice and db/db diabetic mice. It also significantly improved hyperglycemia in both diabetic mice and mitigated proteinuria in HFD/STZ mice. Meanwhile, DDO-1039 attenuated oxidative stress and inflammation as well as apoptosis in vivo and in podocytes stimulated with palmitic acid and high glucose. Interestingly, we identified podocyte protective factor Tyro3 as a novel Nrf2-regulated gene. In addition, podocyte ferroptosis is reduced via activation of glutathione peroxidase 4 by the novel Nrf2 activator. Innovation and conclusion: DDO-1039 activates the Nrf2-based cytoprotective system to mitigate podocyte injury in the context of diabetes, suggesting the potential of DDO-1039 in the treatment of DKD. Antioxid. Redox Signal. 42, 787-806.

Subjects

MeSH terms (MEDLINE)

PodocytesDiabetic NephropathiesOxidative StressNF-E2-Related Factor 2FerroptosisInflammationAnimalsMiceHumansDiabetes Mellitus, ExperimentalMaleDisease Models, Animal

Author keywords

Keap1-Nrf2 pathwayROSapoptosisdiabetic kidney diseaseferroptosisinflammationpodocyte

Substances

NF-E2-Related Factor 2

Authors and institutions

  • National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Clinical Research Center, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
  • Nanjing University School of Medicine, Nanjing, China.
  • State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China.

ORCID profiles: Xing Liu

Cite

APA

Liu, X., Zhai, X., Wang, X., Zhu, X., Wang, Z., Jiang, Z., Bao, H., & Chen, Z. (2025). Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis. Antioxidants & Redox Signaling, 42(13-15), 787-806. https://doi.org/10.1089/ars.2024.0653

Vancouver

Liu X, Zhai X, Wang X, Zhu X, Wang Z, Jiang Z, et al. Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis. Antioxidants & Redox Signaling. 2025;42(13-15):787-806. doi:10.1089/ars.2024.0653

BibTeX
@article{Liu2025,
  author = {Liu, Xing and Zhai, Xiuwen and Wang, Xiaoyu and Zhu, Xiaodong and Wang, Ziyue and Jiang, Zhengyu and Bao, Hao and Chen, ZhaoHong},
  title = {Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis},
  journal = {Antioxidants & Redox Signaling},
  year = {2025},
  volume = {42},
  number = {13-15},
  pages = {787--806},
  doi = {10.1089/ars.2024.0653}
}
Start for free →